20 nights
Check In
Jan 05th
Check Out
Jan 25th
You are reading:
Healthy Participants
|
The Resilience Study
Healthy Participants
The Resilience Study
Start date
Jan 05th
Renumeration
$10,500
20 nights, 1 appointment, 1 phone call
Help Test a New Treatment for B-Cell Malignancies
This clinical study is evaluating a new treatment for B-Cell Malignancies. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
Schedule
Cohort 3
1
phone call
Feb 21st
1
appointment
Jan 31st
To Qualify, You Must
Age
Be 18 to 60 years old
Gender
Both males or females
Must be a woman of non-childbearing potential
Physical Condition
Have no significant medical health conditions or allergies
Requirements
Have a BMI between 18 and 32kg/m2
Renumeration
$10,500 *Screening Reimbursement of $100–$250 applies, please see Terms
Help Test a New Treatment for B-Cell Malignancies
Spots are limited. Find out if you qualify today!
Close
Not sure yet? Keep me updated on paid clinical trials at Linear
Get notified about the latest trials each month and find one that fits your interests and schedule.
"*" indicates required fields